PO24 | Emicizumab prophylaxis and bleeding outcomes: a single center clinical experience
Background and Aims: Emicizumab for hemophilia A (HA) has been increasingly employed in clinical practice. The aim is describing our real-world experience and clinical outcomes in severe HA patients (pts). Methods: Retrospective, single-center study including severe HA pts, with/without inhibito...
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
PAGEPress Publications
2025-08-01
|
| Series: | Bleeding, Thrombosis and Vascular Biology |
| Subjects: | |
| Online Access: | https://www.btvb.org/btvb/article/view/285 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|